The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart ...
Much of the conversation at THT revolved around how use of the device would be handled outside of specialized centers.
Acquired by J&J in August 2024 in a deal worth $16.6bn, Abiomed delivered a 13.2% growth, which was driven by demand for Impella ... a coronary artery disease device specialist bought by J ...
Hosted on MSN24d
Johnson & Johnson (JNJ) Q4 2024 Earnings Call TranscriptThink about heart recovery and the impact of Abiomed's Impella heart pumps and the promise ... I was hoping to just ask about the medical device or the sector -- the business, excuse me, and ...
including their approved indications and important safety and risk information associated with the use of the devices, please visit www.impella.com. Based in Danvers, Massachusetts, USA, Abiomed ...
A new life-saving technology is now at Christus Spohn Hospital Shoreline, making them the first hospital in South Texas to ...
The goal of the trial was to evaluate treatment with an Impella percutaneous left ventricular assist device (LVAD) compared with an intra-aortic balloon pump (IABP) in patients with cardiogenic ...
For 5 weeks, the tiny Impella kept Katrina Penney's failed heart pumping while a second heart transplant was secured.
Think about heart recovery and the impact of Abiomed's Impella heart pumps and the promise of V-Waves minimally invasive interatrial shunt. Think about mental health and the impact of our INVEGA ...
"We have reached a new stage in the phased rollout of version 24H2. Eligible devices running Home and Pro editions of Windows 11, versions 23H3 and 22H2 will be gradually updated to version 24H2 ...
Good morning and welcome to Johnson & Johnson's fourth quarter 2024 earnings conference call. All participants will be in a listen-only mode until the question-and-answer session of the conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results